Published Monday, 24 November -Issue #11
3 Quick Bites: Last Week in Dementia News
Chris Hemsworth Shares His Father’s Alzheimer’s Journey: A Road Trip to Remember
National Geographic / Disney+ • Streaming Now
Story:
In his new documentary A Road Trip to Remember, Chris Hemsworth travels across Australia with his father, Craig, following his Alzheimer’s diagnosis. Guided by dementia specialist Dr Siraj Sattan, their journey explores science-backed approaches such as reminiscence therapy, social connection and community engagement as ways to support the brain after diagnosis. Sattan’s research, based on more than 40,000 people across 14 countries, shows that regular social interaction can cut dementia risk in half and may slow decline even after diagnosis. Through familiar landscapes, photographs and conversations, the film shows how connection can still support the brain, even after symptoms have begun.
Why it matters:
The film includes a full recreation of the Hemsworth family home, which most people would never be able to do. But the science behind reminiscence therapy doesn’t require a television set or a budget. A photo album, an old song, a familiar street or a conversation about the past can still stimulate memory, tools that don’t require medication or specialist care. It brings science and everyday life closer together.
When public figures such as Chris Hemsworth, Bruce Willis, Rosalynn Carter, Terry Pratchett and Tony Christie speak openly about dementia, it helps bring dementia into mainstream conversation and makes it easier for families to speak openly too.
My take:
The film offers something many caregivers understand instinctively: that companionship, love, and shared moments still matter, even when memory begins to fade. When you watch the film and see Chris’s face in moments of the film, you understand truly what going on in his mind. It reminds us that even when memories begin to fade, there are still ways to connect, still ways to show up, and still moments worth keeping.
A Simple Amino Acid Shows Early Promise in Alzheimer’s Models
ScienceDaily • 21 Nov 2025 • Read it here
Story:
Researchers tested the amino acid arginine in animal models (flies and mice) of Alzheimer’s. This is a pre-clinical study, meaning no humans were involved. In lab tests, flies, and mice, oral arginine blocked harmful amyloid-beta (Aβ) buildup, lowered plaque levels, and cut inflammation. It also improved behavior in mice, showing broad neuroprotective effects .It suggests arginine may have potential as a future treatment, but it is still at the laboratory stage, far from real-world testing.
Why it matters:
Caregivers often hear about “breakthroughs” without knowing how close they are to everyday life. This one is encouraging but distant. It’s the first step on a long path, from lab models to human trials, before anyone knows if it could help people.
My take:
Studies like this remind me that science is still moving forward, but also that as caregivers we live in the present tense. This research is not ready for treatment, but it is another sign that researchers are still searching, still experimenting. Arginine is already available as a supplement for humans, but this study only involved animals. We don’t yet know if it helps people with dementia and no treatment guidance on dosage, safety etc exists.
Exercising in Mid and Later Life Can Reduce Dementia Risk
The Conversation •19 Nov 2025 • Read it here
Story:
Using data from the Framingham Heart Study, which has tracked adults since the 1970s with regular health and memory assessments, researchers found that people who stayed physically active in mid-life and later life had a lower risk of developing dementia. Everyday movement, walking, gardening, housework, counted just as much as formal exercise. The article explains how activity may protect the brain through blood flow, reduced inflammation and stronger “cognitive reserve,” helping the brain cope for longer even when changes begin.
Why it matters:
It makes prevention feel realistic. Movement doesn’t need to be intense, just regular and woven into daily life. It also shifts the focus from guilt about past habits to what can still be done now.
My take:
What reassured me is that this comes from decades of real-life data, not just short trials. It suggests that even later in life, activity can still matter. For caregivers, movement can be more than health, it can be structure, connection and purpose.
You might ask how this differs from a previous report on walking 3000 steps story, the:-
Walking 3,000 steps story – An observational study based on current activity levels “There’s something you can try today, and it might help.” (Focus: slowing decline in people already at risk)
Framingham study story – A long-term cohort study following people since the 1970s “Your past doesn’t rule you out, what you do now still matters, even later in life.” (Focus: lowering future dementia risk across decades)
Thank you for reading
Memory Matters Weekly aims to help caregivers, and families stay informed without the jargon. If you found this useful, feel free to share it.
See you next Monday.